NASDAQ:SYNH Syneos Health (SYNH) Stock Forecast, Price & News $41.52 -0.04 (-0.10%) (As of 03:23 PM ET) Add Compare Share Share Today's Range$41.40▼$41.6150-Day Range$34.33▼$41.8552-Week Range$22.89▼$79.77Volume1.79 million shsAverage Volume2.24 million shsMarket Capitalization$4.30 billionP/E Ratio29.03Dividend YieldN/APrice Target$47.63 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Syneos Health MarketRank™ ForecastAnalyst RatingHold2.00 Rating ScoreUpside/Downside14.6% Upside$47.63 Price TargetShort InterestHealthy2.57% of Float Sold ShortDividend StrengthN/ASustainability-1.00Upright™ Environmental ScoreNews Sentiment0.97Based on 6 Articles This WeekInsider TradingN/AProj. Earnings Growth25.35%From $2.84 to $3.56 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.62 out of 5 starsMedical Sector85th out of 980 stocksCommercial Physical Research Industry4th out of 16 stocks 2.0 Analyst's Opinion Consensus RatingSyneos Health has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 9 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $47.63, Syneos Health has a forecasted upside of 14.6% from its current price of $41.54.Amount of Analyst CoverageSyneos Health has only been the subject of 4 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted2.57% of the float of Syneos Health has been sold short.Short Interest Ratio / Days to CoverSyneos Health has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Syneos Health has recently decreased by 8.01%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldSyneos Health does not currently pay a dividend.Dividend GrowthSyneos Health does not have a long track record of dividend growth. Previous Next 4.5 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreSyneos Health has received a 70.43% net impact score from Upright. The largest positive contribution comes from its "Creating knowledge" impact, which is mostly driven by its "Clinical research services for physical health", "Clinical research services for mental health", and "Management consulting for medical technology industry" products. See details.Environmental SustainabilityThe Environmental Impact score for Syneos Health is -1.00. Previous Next 2.8 News and Social Media Coverage News SentimentSyneos Health has a news sentiment score of 0.97. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Syneos Health this week, compared to 5 articles on an average week.MarketBeat FollowsOnly 2 people have added Syneos Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Syneos Health insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.34% of the stock of Syneos Health is held by insiders.Percentage Held by Institutions93.51% of the stock of Syneos Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Syneos Health are expected to grow by 25.35% in the coming year, from $2.84 to $3.56 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Syneos Health is 29.05, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 120.92.Price to Earnings Ratio vs. SectorThe P/E ratio of Syneos Health is 29.05, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 89.73.Price to Book Value per Share RatioSyneos Health has a P/B Ratio of 1.22. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Syneos Health (NASDAQ:SYNH) StockSyneos Health, Inc. engages in the provision of biopharmaceutical solutions. It operates through the Clinical Solutions and Commercial Solutions segments. The Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. It also offers individual services including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, and consultancy services. The company was founded in 1998 and is headquartered in Morrisville, NC.Read More Receive SYNH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Syneos Health and its competitors with MarketBeat's FREE daily newsletter. Email Address SYNH Stock News HeadlinesJune 4, 2023 | americanbankingnews.comSyneos Health (NASDAQ:SYNH) Now Covered by Analysts at StockNews.comMay 30, 2023 | americanbankingnews.comResearch Analysts Issue Forecasts for Syneos Health, Inc.'s Q2 2023 Earnings (NASDAQ:SYNH)June 5, 2023 | Edge On The Street (Ad)Investor Alert: EV Initiatives Create Unsustainable Demand For LithiumThe soaring demand for lithium is driven by worldwide demand for electric vehicles (EVs). Lithium is ideal for electric cars. It's lightweight, stores lots of energy and is rechargeable. Sales of EVs are expected to increase 10-fold by 2030 and estimates are that 1 in 2 cars sold will be electric by 2040.May 27, 2023 | americanbankingnews.comSyneos Health (NASDAQ:SYNH) Coverage Initiated by Analysts at StockNews.comMay 26, 2023 | msn.comFivepHusion team up with Treehill Partners and Syneos HealthMay 25, 2023 | finance.yahoo.comSyneos Health Appoints Batisha Anson to Global Head, Patient Diversity and Health EquityMay 25, 2023 | finance.yahoo.comSyneos Health Appoints Batisha Anson to Global Head, Patient Diversity and Health EquityMay 19, 2023 | americanbankingnews.comMizuho Raises Syneos Health (NASDAQ:SYNH) Price Target to $43.00June 5, 2023 | Edge On The Street (Ad)New "Mined in America" Lithium Opportunities?The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.May 19, 2023 | americanbankingnews.comSyneos Health (NASDAQ:SYNH) Sees Strong Trading Volume Following Analyst UpgradeMay 17, 2023 | americanbankingnews.comSyneos Health, Inc. (NASDAQ:SYNH) Given Average Rating of "Hold" by BrokeragesMay 16, 2023 | msn.comMizuho Maintains Syneos Health Inc - (SYNH) Neutral RecommendationMay 16, 2023 | markets.businessinsider.com8 Analysts Have This to Say About Syneos HealthMay 16, 2023 | finance.yahoo.comSyneos Health Leaders Recognized as PM360 2023 ELITE Award RecipientsMay 14, 2023 | americanbankingnews.comSyneos Health (NASDAQ:SYNH) Downgraded by Robert W. Baird to "Neutral"May 13, 2023 | americanbankingnews.comSyneos Health (NASDAQ:SYNH) Sees Large Volume IncreaseMay 12, 2023 | bizjournals.comInvestment firms to take North Carolina health-care giant Syneos private in $7.1B dealMay 12, 2023 | americanbankingnews.comSyneos Health (NASDAQ:SYNH) Shares Gap Up to $38.45May 12, 2023 | americanbankingnews.comSyneos Health (NASDAQ:SYNH) Lowered to "Hold" at Deutsche Bank AktiengesellschaftMay 12, 2023 | americanbankingnews.comBarclays Upgrades Syneos Health (NASDAQ:SYNH) to Equal WeightMay 11, 2023 | msn.comBarclays Upgrades Syneos Health Inc - (SYNH)May 11, 2023 | benzinga.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Syneos Health, Inc. BuyoutMay 11, 2023 | marketwatch.comShareholder Alert: Ademi LLP investigates whether Syneos Health, Inc. has obtained a Fair Price in its transaction with the Investment ConsortiumMay 11, 2023 | marketwatch.comSYNH STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Syneos Health, Inc. Is Fair to ShareholdersMay 11, 2023 | markets.businessinsider.comRobert W. Baird downgrades Syneos Health (SYNH) to a HoldMay 11, 2023 | bizjournals.comInvestment firms to take Syneos private in $7B dealMay 11, 2023 | americanbankingnews.comSyneos Health (NASDAQ:SYNH) Stock Rating Upgraded by JPMorgan Chase & Co.See More Headlines SYNH Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SYNH Company Calendar Last Earnings11/03/2021Today6/05/2023Next Earnings (Estimated)8/01/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Commercial physical research Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SYNH CUSIPN/A CIK1610950 Webwww.syneoshealth.com Phone(919) 876-9300Fax919-876-9360Employees29,395Year FoundedN/APrice Target and Rating Average Stock Price Forecast$47.63 High Stock Price Forecast$73.00 Low Stock Price Forecast$28.00 Forecasted Upside/Downside+14.6%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)$1.43 Trailing P/E Ratio29.06 Forward P/E Ratio14.63 P/E GrowthN/ANet Income$266.50 million Net Margins2.74% Pretax Margin3.43% Return on Equity12.14% Return on Assets5.06% Debt Debt-to-Equity Ratio0.77 Current Ratio1.15 Quick Ratio1.15 Sales & Book Value Annual Sales$5.39 billion Price / Sales0.80 Cash Flow$6.71 per share Price / Cash Flow6.19 Book Value$33.96 per share Price / Book1.22Miscellaneous Outstanding Shares103,650,000Free Float103,295,000Market Cap$4.31 billion OptionableOptionable Beta1.61 Key ExecutivesMichelle KeefeChief Executive Officer & DirectorMichael BrooksChief Operating OfficerStanford RudnickChief Financial OfficerLarry A PickettChief Information & Digital OfficerBaba ShettyPresident-Technology & Data SolutionsKey CompetitorsMedpaceNASDAQ:MEDPCharles River Laboratories InternationalNYSE:CRLIncyteNASDAQ:INCYICON PublicNASDAQ:ICLRHalozyme TherapeuticsNASDAQ:HALOView All CompetitorsInsiders & InstitutionsMacquarie Group Ltd.Bought 1,979 shares on 6/1/2023Ownership: 0.005%ProShare Advisors LLCSold 3,133 shares on 5/26/2023Ownership: 0.013%Brandywine Global Investment Management LLCSold 41,141 shares on 5/25/2023Ownership: 0.733%Toroso Investments LLCBought 10,184 shares on 5/23/2023Ownership: 0.010%Ameriprise Financial Inc.Bought 278,953 shares on 5/22/2023Ownership: 1.369%View All Insider TransactionsView All Institutional Transactions SYNH Stock - Frequently Asked Questions Should I buy or sell Syneos Health stock right now? 9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Syneos Health in the last year. There are currently 9 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SYNH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SYNH, but not buy additional shares or sell existing shares. View SYNH analyst ratings or view top-rated stocks. What is Syneos Health's stock price forecast for 2023? 9 Wall Street research analysts have issued twelve-month price targets for Syneos Health's shares. Their SYNH share price forecasts range from $28.00 to $73.00. On average, they predict the company's share price to reach $47.63 in the next twelve months. This suggests a possible upside of 14.6% from the stock's current price. View analysts price targets for SYNH or view top-rated stocks among Wall Street analysts. How have SYNH shares performed in 2023? Syneos Health's stock was trading at $36.68 at the start of the year. Since then, SYNH shares have increased by 13.3% and is now trading at $41.55. View the best growth stocks for 2023 here. When is Syneos Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 1st 2023. View our SYNH earnings forecast. How were Syneos Health's earnings last quarter? Syneos Health, Inc. (NASDAQ:SYNH) posted its quarterly earnings results on Wednesday, November, 3rd. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.17 by $0.05. The firm earned $1.35 billion during the quarter, compared to the consensus estimate of $1.34 billion. Syneos Health had a net margin of 2.74% and a trailing twelve-month return on equity of 12.14%. The firm's revenue for the quarter was up 22.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.93 EPS. What ETFs hold Syneos Health's stock? ETFs with the largest weight of Syneos Health (NASDAQ:SYNH) stock in their portfolio include First Trust Health Care AlphaDEX Fund (FXH), Invesco S&P MidCap 400 Pure Value ETF (RFV), First Trust Nasdaq Pharmaceuticals ETF (FTXH), AI Powered Equity ETF (AIEQ), Syntax Stratified MidCap ETF (SMDY), First Trust Mid Cap Value AlphaDEX Fund (FNK), Vanguard Small-Cap Growth ETF (VBK) and Humankind US Stock ETF (HKND). What is Alistair Macdonald's approval rating as Syneos Health's CEO? 322 employees have rated Syneos Health Chief Executive Officer Alistair Macdonald on Glassdoor.com. Alistair Macdonald has an approval rating of 82% among the company's employees. What other stocks do shareholders of Syneos Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Syneos Health investors own include NVIDIA (NVDA), Pfizer (PFE), Block (SQ), Advanced Micro Devices (AMD), Boeing (BA), Alibaba Group (BABA), ICON Public (ICLR), Netflix (NFLX), AbbVie (ABBV) and Intel (INTC). What is Syneos Health's stock symbol? Syneos Health trades on the NASDAQ under the ticker symbol "SYNH." Who are Syneos Health's major shareholders? Syneos Health's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (10.18%), Wellington Management Group LLP (7.27%), Clearbridge Investments LLC (4.02%), Barclays PLC (2.96%), State Street Corp (2.75%) and FMR LLC (2.68%). Insiders that own company stock include Alistair Macdonald, Donna Hildebrand Kralowetz, International Corp/Ma Advent, Jason M Meggs, John L Maldonado, John M Dineen, Jonathan Olefson, Linda S Harty, Mark E Jagiela, Matthew E Monaghan, Matthew E Monaghan, Michael Lee Brooks, Michelle Keefe, Thomas H Lee Advisors, Llc and Tom Allen. View institutional ownership trends. How do I buy shares of Syneos Health? Shares of SYNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Syneos Health's stock price today? One share of SYNH stock can currently be purchased for approximately $41.55. How much money does Syneos Health make? Syneos Health (NASDAQ:SYNH) has a market capitalization of $4.31 billion and generates $5.39 billion in revenue each year. The company earns $266.50 million in net income (profit) each year or $1.43 on an earnings per share basis. How many employees does Syneos Health have? The company employs 29,395 workers across the globe. How can I contact Syneos Health? Syneos Health's mailing address is 1030 Sync Street, Morrisville NC, 27560. The official website for the company is www.syneoshealth.com. The company can be reached via phone at (919) 876-9300, via email at investor.relations@syneoshealth.com, or via fax at 919-876-9360. This page (NASDAQ:SYNH) was last updated on 6/5/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syneos Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.